Does Prolonged IV Amikacin Therapy Improve Outcomes in M Abscessus?
What is the efficacy of ongoing treatment of Mycobacterium abscessus pulmonary disease with IV amikacin in patients with persistent culture positivity?
What is the efficacy of ongoing treatment of Mycobacterium abscessus pulmonary disease with IV amikacin in patients with persistent culture positivity?
Specialized imaging shows that posthospitalized COVID-19 patients and nonhospitalized patients with post-COVID-19 condition have lung abnormalities.
Can long-COVID lung diseases be better understood and classified via analysis of abnormalities seen on transbronchial lung cryobiopsies?
A clinical trial compared the efficacy of 2 alpha1-proteinase inhibitors, Glassia and Prolastin, for the treatment of patients with alpha1-antitrypsin deficiency.
Researchers assessed the immunomodulatory activity of bacteria in the lung microbiota, which led to a closer analysis on R mucilaginosa’s anti-inflammatory effect.
Researchers conducted a meta-analysis to assess the risk for nontuberculous mycobacterial lung disease in patients who use inhaled corticosteroids.
Firefighters who were on active duty on Sept. 11, 2001 (9/11) may be able to reduce their risk for World Trade Center-Lung Injury (WTC-LI).
This studied focused on primary prescription adherence for obstructive lung diseases among adult patients in primary care over a 3-year period.
Eonsmoke LLC has been ordered to halt illegal sales of 100 unapproved flavored vaping products in the United States.
Median overall survival increased from 10.1 months with anetumab ravtansine to 11.6 months with vinorelbine.